10 Best Stocks to Invest in for Long Term

7. Eli Lilly and Company (NYSE:LLY)

Number of Hedge Fund Holders: 115

Eli Lilly and Company (NYSE:LLY) is a global pharmaceutical company that makes medicines to help people live better lives. The company sells its products in about 95 countries and focuses only on human health. The company makes treatments for diabetes, cancer, immune system diseases, brain disorders, and more. Some of its well-known drugs include Mounjaro and Trulicity for diabetes, Verzenio for breast cancer, and Kisunla for early Alzheimer’s. The company is known for creating new and effective medicines to treat serious health problems.

To deal with rising tariffs and avoid possible supply chain hiccups, Eli Lilly and Company (NYSE:LLY) is setting up production sites in the US, closer to most of its customers. Over the last couple of years, Lilly has been on an acquisition spree, buying eight companies and signing three new partnerships. These moves, starting with DICE Therapeutics in mid-2023 and most recently Scorpion Therapeutics in early 2025, are helping it grow into new areas. The company’s stock got a boost recently after a key diabetes drug, Orforglipron, did well in late-stage testing. The success has investors feeling good about Lilly’s place in the fast-growing market for diabetes and obesity treatments.

Lilly is also investing heavily into research to treat other prominent diseases. It has a deep pipeline with new potential drugs, which would lead to new stream of revenue for the company.